Vanessa Pavinato (@vpavinato) 's Twitter Profile
Vanessa Pavinato

@vpavinato

Head of Comms at European oncology association. Love jazz and classical music. Working mother, commuter for life. Tweets+RT are my own.

ID: 1108686373

linkhttp://www.esmo.org calendar_today21-01-2013 10:32:48

1,1K Tweet

503 Takipçi

483 Takip Edilen

Sara Fontanella Chiarani (@sara_chiarani) 's Twitter Profile Photo

Busy ESMO - Eur. Oncology #ESMO22 press room, journalists relentlessly working to share the important results of these days #DisseminatingScience #StayTuned #HotOffThePress #PressOfficeLife

Busy <a href="/myesmo/">ESMO - Eur. Oncology</a> #ESMO22 press room, journalists relentlessly working to share the important results of these days #DisseminatingScience #StayTuned #HotOffThePress #PressOfficeLife
Dario Trapani (@dariot_) 's Twitter Profile Photo

Did you know that ESMO - Eur. Oncology has a decennial commitment to #CloseTheCareGap? Join the global 🌐 community for the #WorldCancerDay to support all days #cancercareToAll and discover more on the ESMO - Eur. Oncology action 👇👇👇

Dr. Antonio Calles 🫁🚭 (@tony_calles) 's Twitter Profile Photo

Hay UNA SOLA ÚNICA cosa que como oncólogo, y tras cientos de muertes a mis espaldas 😞, decidí que los míos no harían: 1️⃣ Fumar 🚬

EACD (@eacdonline) 's Twitter Profile Photo

How is the changing work landscape redefining the skills we need for effective communication? Join the next #EACD webinar on 12 December to unlock insights on establishing communications in the changing world of work. Register now: bit.ly/47LeieC

Harvard Business Review (@harvardbiz) 's Twitter Profile Photo

An analysis of men and women’s behavior in one company suggests that the difference in their promotion rates wasn’t due to their behavior but to how they were treated. s.hbr.org/47FkPYd

ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

What’s up in oncology? Be at the forefront of #CancerResearch advances with the #ESMODailyReporter, your trusted source for news tailored to the oncology community. 👉ow.ly/Hsgw50RhVCx

What’s up in oncology? Be at the forefront of #CancerResearch advances with the #ESMODailyReporter, your trusted source for news tailored to the oncology community.
👉ow.ly/Hsgw50RhVCx
Luis Castelo-Branco (MD; PharmD; PhD) (@luiscb_medpharm) 's Twitter Profile Photo

More on the advantages of some old rural communities life-style (which many we can replicate in modern cities as well). Sense of belonging to a community, and feeling included is a protective factor for many diseases. But not on "social-media". On real-life.

Vanessa Pavinato (@vpavinato) 's Twitter Profile Photo

And lots of critical messages to pay attention to in the face of increasing nr of #gastrointestinal #cancer diagnoses. Thx Ben Westphalen Andres Cervantes Angela Lamarca @FlorianLordick for the meaningful insights #esmogi24 ESMO - Eur. Oncology Digestive Cancers Europe

Vanessa Pavinato (@vpavinato) 's Twitter Profile Photo

Looking forward to welcoming you and other #climate conscious #oncologists to #Barcelona Setting a good example is an important first step 👏🏻 #esmo24

Myriam Chalabi (@myriamchalabi) 's Twitter Profile Photo

Honored and excited to be scientific co-chair of #ESMO25 together with Toni Choueiri, MD With FabriceAndre as incoming ESMO - Eur. Oncology president on our side we will be giving it our all! See you in #Berlin 🙏 Rebecca Dent for a fantastic, practice-changing #ESMO24. We learn from the best ❗️❗️

Honored and excited to be scientific co-chair of #ESMO25 together with <a href="/DrChoueiri/">Toni Choueiri, MD</a> 
With <a href="/FAndreMD/">FabriceAndre</a> as incoming <a href="/myESMO/">ESMO - Eur. Oncology</a> president on our side we will be giving it our all! See you in #Berlin 
🙏 <a href="/RebeccaDSing/">Rebecca Dent</a> for a fantastic, practice-changing #ESMO24. We learn from the best ❗️❗️
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥Presidential Symposium III: Eyes to the future🔥 The road to personalize targeted therapy and immunotherapy #ESMO24 🔎The Rome trial from histology to target 👉26 drugs for 🎯💊 👉ORR 17 vs 11% 👉mPFS 3.7 vs 2.8 👉mOS ns, 52% cross over 🧐TT w/ significant benefit, MTB crucial

🔥Presidential Symposium III: Eyes to the future🔥
The road to personalize targeted therapy and immunotherapy
#ESMO24
🔎The Rome trial from histology to target
👉26 drugs for 🎯💊
👉ORR 17 vs 11%
👉mPFS 3.7 vs 2.8
👉mOS ns, 52% cross over
🧐TT w/ significant benefit, MTB crucial
ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

📖 ESMO invites you to mark Annals of Oncology ’s 35th Anniversary by exploring significant milestones with the Milestones Monday series, the #DYK post series, exclusive interviews with Editors-in-Chief, and the 2023 most-cited papers of #AnnalsofOncology 🔗 ow.ly/8rwR50U6a4t

📖 ESMO invites you to mark <a href="/Annals_Oncology/">Annals of Oncology</a> ’s 35th Anniversary by exploring significant milestones with the Milestones Monday series, the #DYK post series, exclusive interviews with Editors-in-Chief, and the 2023 most-cited papers of #AnnalsofOncology
🔗 ow.ly/8rwR50U6a4t
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Numbers that I am still digesting from todayat @myesmo #ESMOGI25 come from the #KeynoteLecture by #ElisabeteWeiderpass Take home message 1/3 🧵 🌍 Burden of type of GI cancer varies accross countries #ESMOAmbassadors

Numbers that I am still digesting from todayat @myesmo #ESMOGI25 come from the #KeynoteLecture by #ElisabeteWeiderpass

Take home message 1/3 🧵
🌍 Burden of type of GI cancer varies accross countries

#ESMOAmbassadors